Literature DB >> 17634222

Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC.

Keith W Jarosinski1, Neil G Margulis, Jeremy P Kamil, Stephen J Spatz, Venugopal K Nair, Nikolaus Osterrieder.   

Abstract

Marek's disease virus (MDV) causes a general malaise in chickens that is mostly characterized by the development of lymphoblastoid tumors in multiple organs. The use of bacterial artificial chromosomes (BACs) for cloning and manipulation of the MDV genome has facilitated characterization of specific genes and genomic regions. The development of most MDV BACs, including pRB-1B-5, derived from a very virulent MDV strain, involved replacement of the US2 gene with mini-F vector sequences. However, when reconstituted viruses based on pRB-1B were used in pathogenicity studies, it was discovered that contact chickens housed together with experimentally infected chickens did not contract Marek's disease (MD), indicating a lack of horizontal transmission. Staining of feather follicle epithelial cells in the skins of infected chickens showed that virus was present but was unable to be released and/or infect susceptible chickens. Restoration of US2 and removal of mini-F sequences within viral RB-1B did not alter this characteristic, although in vivo viremia levels were increased significantly. Sequence analyses of pRB-1B revealed that the UL13, UL44, and US6 genes encoding the UL13 serine/threonine protein kinase, glycoprotein C (gC), and gD, respectively, harbored frameshift mutations. These mutations were repaired individually, or in combination, using two-step Red mutagenesis. Reconstituted viruses were tested for replication, MD incidence, and their abilities to horizontally spread to contact chickens. The experiments clearly showed that US2, UL13, and gC in combination are essential for horizontal transmission of MDV and that none of the genes alone is able to restore this phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634222      PMCID: PMC2045466          DOI: 10.1128/JVI.01065-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus.

Authors:  M Niikura; J Dodgson; H Cheng
Journal:  Arch Virol       Date:  2005-09-09       Impact factor: 2.574

2.  Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains.

Authors:  V Feenstra; M Hodaie; D C Johnson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I.

Authors:  T I Ng; W O Ogle; B Roizman
Journal:  Virology       Date:  1998-02-01       Impact factor: 3.616

4.  The equine herpesvirus 1 Us2 homolog encodes a nonessential membrane-associated virion component.

Authors:  A Meindl; N Osterrieder
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens.

Authors:  M Niikura; R L Witter; H K Jang; M Ono; T Mikami; R F Silva
Journal:  Acta Virol       Date:  1999 Apr-Jun       Impact factor: 1.162

6.  The UL48 tegument protein of pseudorabies virus is critical for intracytoplasmic assembly of infectious virions.

Authors:  Walter Fuchs; Harald Granzow; Barbara G Klupp; Martina Kopp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  A full UL13 open reading frame in Marek's disease virus (MDV) is dispensable for tumor formation and feather follicle tropism and cannot restore horizontal virus transmission of rRB-1B in vivo.

Authors:  Caroline Blondeau; Najet Chbab; Catherine Beaumont; Katia Courvoisier; Nikolaus Osterrieder; Jean-François Vautherot; Caroline Denesvre
Journal:  Vet Res       Date:  2007-03-13       Impact factor: 3.683

8.  The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress.

Authors:  Jens von Einem; Daniel Schumacher; Dennis J O'Callaghan; Nikolaus Osterrieder
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus.

Authors:  Andrew C Brown; Susan J Baigent; Lorraine P Smith; Jason P Chattoo; Lawrence J Petherbridge; Pippa Hawes; Martin J Allday; Venugopal Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

10.  A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Authors:  Sascha Trapp; Mark S Parcells; Jeremy P Kamil; Daniel Schumacher; B Karsten Tischer; Pankaj M Kumar; Venugopal K Nair; Nikolaus Osterrieder
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  63 in total

1.  The Herpesviridae Conserved Multifunctional Infected-Cell Protein 27 (ICP27) Is Important but Not Required for Replication and Oncogenicity of Marek's Disease Alphaherpesvirus.

Authors:  Nagendraprabhu Ponnuraj; Yung-Tien Tien; Widaliz Vega-Rodriguez; Andrea Krieter; Keith W Jarosinski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

4.  Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis.

Authors:  Annachiara Greco; Nadine Fester; Annemarie T Engel; Benedikt B Kaufer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Multiple Roles of the Cytoplasmic Domain of Herpes Simplex Virus 1 Envelope Glycoprotein D in Infected Cells.

Authors:  Jun Arii; Keiko Shindo; Naoto Koyanagi; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

6.  A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis.

Authors:  Jun Arii; Jing Wang; Tomomi Morimoto; Tadahiro Suenaga; Hiroomi Akashi; Hisashi Arase; Yasushi Kawaguchi
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

7.  Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Authors:  Johnathan Storlie; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Virology       Date:  2008-10-26       Impact factor: 3.616

8.  Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.

Authors:  Gerlinde R Van de Walle; Sarah T Peters; Brian C VanderVen; Dennis J O'Callaghan; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).

Authors:  Najat Chbab; Annemarie Egerer; Inês Veiga; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

10.  Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Authors:  Benedikt B Kaufer; Sascha Trapp; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.